A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology

被引:7
|
作者
Grosman, Benyamin [1 ,2 ]
Roy, Anirban [1 ]
Lintereur, Louis [1 ]
Turksoy, Kamuran [1 ]
Benedetti, Andrea [1 ]
Cordero, Toni L. [1 ]
Vigersky, Robert A. [1 ]
Mcvean, Jennifer [1 ]
Rhinehart, Andrew S. [1 ]
Cohen, Ohad [1 ]
机构
[1] Medtron Diabet, Northridge, CA USA
[2] Medtron Diabet, 18000 Devonshire St, Northridge, CA 91325 USA
关键词
Artificial pancreas; Adaptive control; Type; 1; diabetes; Advanced hybrid closed loop; Automated insulin delivery; Algorithm; LOOP INSULIN DELIVERY; GLUCOSE; SYSTEM;
D O I
10.1089/dia.2023.0446
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The MiniMed (TM) 780G system (780G) received Conformite Europeenne mark in June 2020 and was, recently, approved by the U.S. Food and Drug Administration (April 2023). Clinical trials and real-world analyses have demonstrated MiniMed (TM) 780G system safety and effectiveness and that glycemic outcomes (i.e., time in range) improve with recommended settings use. In this publication, we will explain the iterative development of the 780G algorithm and how this technology has simplified diabetes management.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 50 条
  • [41] THE SIGNIFICANCE OF COEFFICIENT OF VARIATION AS A MEASURE OF HYPOGLYCEMIA RISK AND TIME IN RANGE IN REAL WORLD USERS OF THE MINIMED™ 780G SYSTEM
    Castaneda, J.
    Van Den Heuvel, T.
    Arrieta, A.
    Cohen, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A235 - A235
  • [42] Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
    Jothydev Kesavadev
    Anjana Basanth
    Gopika Krishnan
    Arun Shankar
    Geethu Sanal
    Sunitha Jothydev
    Diabetes Therapy, 2023, 14 : 1319 - 1330
  • [43] Higher Real-World Time in Range Demonstrated in Children Using Recommended MiniMed 780G (AHCL) Settings
    Mcvean, Jennifer
    Arrieta, Arcelia
    Cordero, Toni L.
    Castro, Matias
    Castaneda, Javier
    Cohen, Ohad
    DIABETES, 2023, 72
  • [44] Real world efficacy and safety of the advanced hybrid closed-loop system MiniMed 780G (SmartGuard) in children under 7 years of age
    Lopez-Lopez, Sara
    Diaz-Martin, Cristina
    Garcia-de Pablo, Ines
    Ovejero-Garcia, Maria Teresa
    Garnier-Rodriguez, Maria Beatriz
    Molina-Suarez, Ruth
    Ontoria-Betancort, Cristina
    Saez-Gallego, Blanca
    Dominguez-Garcia, Angela
    Quinteiro-Gonzalez, Sofia
    Travieso-Suarez, Lourdes
    Cabrera-Guedes, Maria Fatima
    Novoa-Medina, Yeray
    FRONTIERS IN MEDICINE, 2025, 11
  • [45] GLYCEMIC OUTCOMES AND SAFETY WITH MINIMED 780G SYSTEM IN CHILDREN WITH TYPE 1 DIABETES AGED 2-6 YEARS
    Tuomaala, A. -K.
    Varimo, T.
    Hakonen, E.
    Kiiveri, S.
    Janer, J.
    Hyvonen, M.
    Wehkalampi, K.
    Laakkonen, H.
    Laakso, S.
    Harsunen, M.
    Hero, M.
    Miettinen, P.
    Pulkkinen, M. -A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A82 - A82
  • [46] MiniMed 780g system and children with type 1 diabetes followed for one year: lessons learned from diabetes educators
    Almajaly, D.
    Petroviski, G.
    Rangarajan, R.
    Campbell, J.
    Pasha, M.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 354 - 354
  • [47] CALIBRATION, METABOLIC CONTROL AND SLEEP QUALITY IN MINIMED 780G TYPE 1 DIABETES COHORT WITH GUARDIAN SENSOR 3 AND 4
    Diaz Soto, G.
    Nieto De la Marca, M. D. L. O.
    Sendin Plaar, K. Benito
    Vidueira Martinez, A.
    Rodriguez Del Rosario, S.
    Fernandez Velasco, P.
    De Luis, D.
    Bahillo Curieses, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A1 - A1
  • [48] Stable glycemic control in or out of school in children using the MiniMed 780g system - a real world study from Italy
    McVean, J.
    Bosi, E.
    Voelker, B.
    Smaniotto, V.
    Arrieta, A.
    Van Den Heuvel, T.
    Castaneda, J.
    Cohen, O.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 79 - 80
  • [49] Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system
    Grassi, Bruno
    Gomez, Ana Maria
    Calliari, Luis Eduardo
    Franco, Denise
    Raggio, Marcela
    Riera, Francisca
    Castro, Matias
    McVean, Jennifer
    van den Heuvel, Tim
    Arrieta, Arcelia
    Castaneda, Javier
    Cohen, Ohad
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1688 - 1697
  • [50] Long-term use of Minimed™ 780G in children and adolescents with type 1 diabetes under real-world conditions: The benefits of optimal settings
    Bombaci, Bruno
    Passanisi, Stefano
    Calderone, Marco
    Macri, Fabio
    Lombardo, Fortunato
    Salzano, Giuseppina
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2309 - 2312